Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
GLP-1 receptor agonists: a novel pharmacotherapy for binge eating (binge eating disorder and bulimia nervosa)
74 Exenatide therapy was associated with lower cardiac enzyme values during the first 72 hours and a reduction in infarct size according to cardiac MRI at 1 month compared with placebo
GLP-1 receptor agonist medications like semaglutide and tirzepatide mimic this hormone at therapeutic levels, creating a powerful, sustained effect that your body's natural GLP-1 alone can't achieve
Some of these medications, such as Ozempic and Mounjaro, have become quite popular for losing weight
)
US$ 20.96
US$ 21.13
.png)
US$ 27.81
